---
schema_version: '1.0'
id: government-20260724-74e659
content_kind: government-document
url: https://www.federalregister.gov/documents/2026/07/24/2026-15016/cellular-tissue-and-gene-therapies-advisory-committee-amendment-of-notice-biologics-license
url_hash: 74e65938a4fe9f5479b952f8575f4d52da45dc0f27e5b6417c74123a8de17d89
canonical_url: https://www.federalregister.gov/documents/2026/07/24/2026-15016/cellular-tissue-and-gene-therapies-advisory-committee-amendment-of-notice-biologics-license
source: us-federal-register
category: government/us
category_raw: Notice
country: us
region: us
tags: []
lang: en
published_at: '2026-07-24T00:00:00Z'
fetched_at: '2026-07-24T09:01:24.948999Z'
updated_at: '2026-07-24T09:05:27Z'
status: published
content_hash: 58325f8707769d75539f229e05a6a720c0be75be13246f1bea873ecb6dd11ece
content_changed_at: null
license_note: full
license_basis: public-domain-17usc105
body_available: false
attribution: 'Source: Office of the Federal Register, National Archives and Records
  Administration'
license_rule: source:us-federal-register
summary: 'The Food and Drug Administration (FDA) is announcing an amendment to the
  notice of meeting of the Cellular, Tissue, and Gene Therapies Advisory Committee
  (the Committee). This meeting was announced in the Federal Register on June 29,
  2026. The amendment is being made to reflect a change in the DATES, ADDRESSES, and
  SUPPLEMENTARY INFORMATION: Procedure portion of the document. There are no other
  changes.'
summary_source: official
summary_en: 'The Food and Drug Administration (FDA) is announcing an amendment to
  the notice of meeting of the Cellular, Tissue, and Gene Therapies Advisory Committee
  (the Committee). This meeting was announced in the Federal Register on June 29,
  2026. The amendment is being made to reflect a change in the DATES, ADDRESSES, and
  SUPPLEMENTARY INFORMATION: Procedure portion of the document. There are no other
  changes.'
provenance:
  doc_id: 2026-15016
  doc_id_scheme: fr_docnum
  issuer:
  - Health and Human Services Department
  - Food and Drug Administration
  doc_type: Notice
  subtype: null
  action: Notice.
  significant: null
entities:
- name: Anderson Taylor
  type: person
- name: general_news
  type: category
key_facts: []
related: []
related_auto:
- name: Guinness World Records
  type: organization
  weight: 1.0
- name: bbc-china
  type: organization
  weight: 1.0
- name: China
  type: country
  weight: 1.0
- name: AI fears mount
  type: UNKNOWN
  weight: 1.0
- name: Czech Military Helicopter
  type: artifact
  weight: 1.0
title: Cellular, Tissue, and Gene Therapies Advisory Committee; Amendment of Notice-Biologics
  License Application (BLA) 125842 From Capricor, Inc. for Deramiocel (Human Allogeneic
  Cardiosphere-Derived Cells)
---

# Cellular, Tissue, and Gene Therapies Advisory Committee; Amendment of Notice-Biologics License Application (BLA) 125842 From Capricor, Inc. for Deramiocel (Human Allogeneic Cardiosphere-Derived Cells)

## TL;DR
The Food and Drug Administration (FDA) is announcing an amendment to the notice of meeting of the Cellular, Tissue, and Gene Therapies Advisory Committee (the Committee). This meeting was announced in the Federal Register on June 29, 2026. The amendment is being made to reflect a change in the DATES, ADDRESSES, and SUPPLEMENTARY INFORMATION: Procedure portion of the document. There are no other changes.

## Key Points
- (なし)

## Details
(本文なし。リンク先参照)

## Source
元記事: [Cellular, Tissue, and Gene Therapies Advisory Committee; Amendment of Notice-Biologics License Application (BLA) 125842 From Capricor, Inc. for Deramiocel (Human Allogeneic Cardiosphere-Derived Cells)](https://www.federalregister.gov/documents/2026/07/24/2026-15016/cellular-tissue-and-gene-therapies-advisory-committee-amendment-of-notice-biologics-license) — published 2026-07-24T00:00:00Z